Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation (Q44781829)

6 December 2017

Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation (English)

1 reference

6 December 2017

1 reference

5

1 reference

6 December 2017

7

Tom Eirik Mollnes

1 reference

6 December 2017

Knut Tore Lappegård

1

1 reference

6 December 2017

Michael Fung

2

1 reference

6 December 2017

Grethe Bergseth

3

1 reference

6 December 2017

Johan Riesenfeld

4

1 reference

6 December 2017

Vibeke Videm

6

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

The Annals of Thoracic Surgery

6 December 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

6 December 2017

77

1 reference

6 December 2017

932-941

1 reference

6 December 2017

3

1 reference

Inflammatory response to cardiopulmonary bypass

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Inflammatory response to cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Mechanisms of the systemic inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Heparin-coated cardiopulmonary bypass circuits: current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Complement metabolism during membrane plasma separation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Biocompatibility of blood tubings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

In vitro investigation of the blood response to medical grade PVC and the effect of heparin on the blood response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

A New Model for Evaluation of Biocompatibility: Combined Determination of Neoepitopes in Blood and on Artificial Surfaces Demonstrates Reduced Complement Activation by Immobilization of Heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Immobilized heparin inhibits the increase in leukocyte surface expression of adhesion molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

A novel enzyme immunoassay for plasma thrombospondin. Comparison with beta-thromboglobulin as platelet activation marker in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

A neoepitope-based enzyme immunoassay for quantification of C1-inhibitor in complex with C1r and C1s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Quantification in Enzyme-Linked Immunosorbent Assay of a C3 Neoepitope Expressed on Activated Human Complement Factor C3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Heparin in clinical doses 'primes' granulocytes to subsequent activation as measured by myeloperoxidase release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

An enzyme linked immunosorbent assay for measurements of lactoferrin in duodenal aspirates and other biological fluids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Cardiopulmonary bypass: Evidence or experience based?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Plasma levels of main granulocyte components during hemodialysis. Comparison of new and reused dialyzers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Role of C3 cleavage in monocyte activation during extracorporeal circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

On the blood compatibility of end-point immobilized heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Biomaterial development for cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Hemocompatibility of heparin-coated surfaces and the role of selective plasma protein adsorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Mechanism of complement activation during extracorporeal blood-biomaterial interaction: effects of heparin coated and uncoated surfaces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Heparin binding and augmentation of C1 inhibitor activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Modification of the complement binding properties of polystyrene: effects of end-point heparin attachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Control of contact activation on end-point immobilized heparin: the role of antithrombin and the specific antithrombin-binding sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Inhibition of Heparin/Protamine Complex-Induced Complement Activation by Compstatin in Baboons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

Total complement inhibition: an effective strategy to limit ischemic injury during coronary revascularization on cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901519-4

10.1016/S0003-4975(03)01519-4

7 January 2021

Identifiers

DOI

1 reference

6 December 2017

1 reference